Literature DB >> 9451745

Alcohol and cancer: a review for psycho-oncologists.

J C Lundberg1, S D Passik.   

Abstract

Researchers have documented a link between alcohol consumption and the development of certain types of cancers. In addition, the prevalence of alcoholism and comorbid psychiatric disorders has been well-documented both the general population and medical settings. The role of the psycho-oncologist in the assessment and management of alcoholism and comorbid psychiatric disorders is crucial to improving both treatment adherence and the quality of life of the patient. This paper will provide psycho-oncologists with a review of: (1) the relationship of alcoholism to cancer; (2) psychiatric comorbidity frequently encountered in alcoholics, as a key to assessment and management; and (3) the goals and strategies of management of alcoholic cancer patient.

Entities:  

Mesh:

Year:  1997        PMID: 9451745     DOI: 10.1002/(SICI)1099-1611(199712)6:4<253::AID-PON276>3.0.CO;2-3

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  4 in total

Review 1.  Quality of life in alcohol-dependent subjects--a review.

Authors:  J H Foster; J E Powell; E J Marshall; T J Peters
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

2.  Opioid therapy in patients with a history of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 3.  Alcohol and Cancer: Existing Knowledge and Evidence Gaps across the Cancer Continuum.

Authors:  Susan M Gapstur; Elisa V Bandera; David H Jernigan; Noelle K LoConte; Brian G Southwell; Vasilis Vasiliou; Abenaa M Brewster; Timothy S Naimi; Courtney L Scherr; Kevin D Shield
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-02       Impact factor: 4.090

Review 4.  Alcohol-Mediated Organ Damages: Heart and Brain.

Authors:  Adam Obad; Ahmed Peeran; Janay I Little; Georges E Haddad; Sima T Tarzami
Journal:  Front Pharmacol       Date:  2018-02-13       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.